Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-05

Clinical Trial Update: A Study Evaluating the Efficacy of Fluocinonide Cream 0.1% (Vanos) in Subjects With Atopic Dermatitis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating fluocinonide cream 0.1% for atopic dermatitis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluocinonide cream 0.1% (Vanos) (fluocinonide)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Atopic Dermatitis | Phase 4 | Status: COMPLETED | Results posted: 2013-03-05